Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
ICRC appoints new director-general
10/31/2019. The Assembly of the International Committee of the Red Cross (ICRC) has appointed Robert Mardini to the post of director-general.
Afghanistan: Six ICRC staff members killed and two unaccounted for in attack
02/08/2017.”This is a despicable act. Nothing can justify the murder of our colleagues and dear friends,” Monica Zanarelli, head of the ICRC delegation in Afghanistan.
Children bear ‘disproportionate lethal impact’ of Syrian war, warns study
According to estimates, one in four civilians killed in 2016 was under the age of 18.
